
Theratechnologies Investor Relations Material
Latest events

Q3 2024
Theratechnologies
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Theratechnologies Inc
Access all reports
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in cardiology, oncology, and women's health. The company primarily develops peptide-based therapeutics. Its product candidates include Onbrez Breezhaler, which is in Phase III clinical trial for the symptomatic relief of chronic obstructive pulmonary disease; and Theratears for Atopic Keratoconjunctivitis (MK), which is under Phase III clinical trial for the treatment of atopic keratoconjunctivitis. Theratechnologies Inc is headquartered in Montreal, Canada.
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
TH
Country
🇨🇦 Canada